-
1
-
-
0023124396
-
-
a) Glaser, B.M.; Cardin, A.; Biscoe, B. Ophthalmology 1987, 94, 327.
-
(1987)
Ophthalmology
, vol.94
, pp. 327
-
-
Glaser, B.M.1
Cardin, A.2
Biscoe, B.3
-
4
-
-
0020622557
-
-
a) Stern, W.; Geoffrey, L.P.; Erickson, P.; Guerin, G.; Anderson, D.; Fisher, S.; O'Donnell, J. Am. J. Ophthalmol. 1983, 96, 33.
-
(1983)
Am. J. Ophthalmol.
, vol.96
, pp. 33
-
-
Stern, W.1
Geoffrey, L.P.2
Erickson, P.3
Guerin, G.4
Anderson, D.5
Fisher, S.6
O'Donnell, J.7
-
5
-
-
0021142362
-
-
b) Blumenkranz, M.S.; Claflin, A.; Hajek, A.S. Arch. Ophthalmol. 1984, 102, 598.
-
(1984)
Arch. Ophthalmol.
, vol.102
, pp. 598
-
-
Blumenkranz, M.S.1
Claflin, A.2
Hajek, A.S.3
-
6
-
-
0003021631
-
-
Manzanas, I.; Marin, J.; Refojo, M.F. Invest. Ophthalmol. Vis. Sci. 1990, 31 (suppl), 24.
-
(1990)
Invest. Ophthalmol. Vis. Sci.
, vol.31
, Issue.SUPPL.
, pp. 24
-
-
Manzanas, I.1
Marin, J.2
Refojo, M.F.3
-
7
-
-
0029983211
-
-
a) Beall, H.D.; Prankerd, R.J.; Sloan, K.B. Drug Dev. and Ind. Pharm. 1996, 22, 85.
-
(1996)
Drug Dev. and Ind. Pharm.
, vol.22
, pp. 85
-
-
Beall, H.D.1
Prankerd, R.J.2
Sloan, K.B.3
-
8
-
-
0027310164
-
-
b) Beall, H.D.; Prankerd, R.J.; Todaro, L.J.; Sloan, K.B. Pharm. Res. 1993, 10, 905.
-
(1993)
Pharm. Res.
, vol.10
, pp. 905
-
-
Beall, H.D.1
Prankerd, R.J.2
Todaro, L.J.3
Sloan, K.B.4
-
9
-
-
0030982644
-
-
c) Beall, H.D.; Prankerd, R.J.; Sloan, K.B. Drug Dev. and Ind. Pharm. 1997, 23, 517.
-
(1997)
Drug Dev. and Ind. Pharm.
, vol.23
, pp. 517
-
-
Beall, H.D.1
Prankerd, R.J.2
Sloan, K.B.3
-
10
-
-
0344656001
-
-
note
-
Typical experimental procedure for both methods: Method 1: in a first step, reaction of a suitable acid (1.5 mmol) with oxalyl chloride (7.5 mmol) in dry toluene (20 ml) for 1 hour led to the desired acid chloride. At the same time, stirring FU (1.02 mmol) with potassium hydroxyde (1 mmol) in methanol (5 ml) for 30 minutes gave the potassium salt of FU. In a second step, the acid chloride was added dropwise to a solution, refrigerated at 0°C, containing the white residue of FU potassium salt in acetonitrile (10 ml). The mixture was then stirred at room temperature for 4 hours. Method 2: the carboxylic acid (1 mmol) and FU (1.5 mmol) were dissolved in anhydrous DMF (35 ml), and stirred at 0°C. Triethylamine (3 mmol) and BROP (1.5 mmol) were added. The mixture was then stirred at 0°C for 2 hours.
-
-
-
-
11
-
-
0345518302
-
-
note
-
3F: C, 61.51; H, 8.07; N, 8.97. Found: C, 61.46; H, 7.95; N, 8.98. White solid: mp 92°C.
-
-
-
-
12
-
-
0344655998
-
-
note
-
+, 265 (loss of one FU molecule). Viscous oil.
-
-
-
-
13
-
-
0344655999
-
-
note
-
3F: C, 56.68; H, 5.95; N, 11.02, Found: C, 56.83; H, 6.04; N, 10.98. White solid: mp 77°C.
-
-
-
-
14
-
-
0344224551
-
-
note
-
+, 283 (loss of one FU molecule). Orange solid: mp 151°C.
-
-
-
-
15
-
-
0025057125
-
-
Coste, J.; Dufour, M.J.; Pantaloni, A.; Castro, B. Tetrahedron Lett. 1990, 31, 669.
-
(1990)
Tetrahedron Lett.
, vol.31
, pp. 669
-
-
Coste, J.1
Dufour, M.J.2
Pantaloni, A.3
Castro, B.4
-
16
-
-
0344656000
-
-
note
-
Using another coupling reagent, bromo-tris-pyrrolidino-phosphonium-hexafluorophosphate, can prevent the formation of HMPA, which is very toxic. The by-product formed is tris-pyrrolidinophosphoramide and the yields are close to those obtained with BROP.
-
-
-
|